Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Calandra

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Gut Pathogens|March 15, 2017
Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and <i>Candida albicans</i> eliminationLaura Choteau, Hélène Vancraeyneste, Didier Le Roy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2008
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemiaLaurence Senn, James Owen Robinson, Sabine Schmidt, et al.
The Journal of Infectious Diseases|February 9, 2012
Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6Ivana Rubino, Alix Coste, Didier Le Roy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2009
Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4Thierry Roger, Céline Froidevaux, Didier Le Roy, et al.
Swiss Medical Weekly|August 29, 2006
Treatment options of invasive fungal infections in adultsUrsula Flückiger, Oscar Marchetti, Jacques Bille, et al.
Cytokine|August 18, 2012
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infectionJulie Delaloye, Irma J A De Bruin, Katharine E A Darling, et al.
European Journal of Immunology|June 10, 2022
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctionsIrene T Schrijver, Charlotte Théroude, Nikolaos Antonakos, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2007
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseasesGibson S Kibiki, Andre J A M van der Ven, Anneke Geurts-Moespot, et al.
The Journal of Infection|August 14, 2025
Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL)Francesco Baccelli, Manuela Aguilar-Guisado, Carolina Garcia Vidal, et al.
The Lancet. Infectious Diseases|November 28, 2025
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in LeukaemiaDina Averbuch, Yuri Vanbiervliet, Francesco Baccelli, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Gut Pathogens|March 15, 2017
Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and <i>Candida albicans</i> eliminationLaura Choteau, Hélène Vancraeyneste, Didier Le Roy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2008
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemiaLaurence Senn, James Owen Robinson, Sabine Schmidt, et al.
The Journal of Infectious Diseases|February 9, 2012
Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6Ivana Rubino, Alix Coste, Didier Le Roy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2009
Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4Thierry Roger, Céline Froidevaux, Didier Le Roy, et al.
Swiss Medical Weekly|August 29, 2006
Treatment options of invasive fungal infections in adultsUrsula Flückiger, Oscar Marchetti, Jacques Bille, et al.
Cytokine|August 18, 2012
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infectionJulie Delaloye, Irma J A De Bruin, Katharine E A Darling, et al.
European Journal of Immunology|June 10, 2022
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctionsIrene T Schrijver, Charlotte Théroude, Nikolaos Antonakos, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2007
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseasesGibson S Kibiki, Andre J A M van der Ven, Anneke Geurts-Moespot, et al.
The Journal of Infection|August 14, 2025
Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL)Francesco Baccelli, Manuela Aguilar-Guisado, Carolina Garcia Vidal, et al.
The Lancet. Infectious Diseases|November 28, 2025
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in LeukaemiaDina Averbuch, Yuri Vanbiervliet, Francesco Baccelli, et al.
Pageof 19